HER2-positive Breast CancerФаза 2NCT07102381
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Zanidatamab, Paclitaxel, Docetaxel, Carboplatin
63 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Breast63 studies
HER2-positive Breast CancerФаза 2NCT07102381
Zanidatamab, Paclitaxel, Docetaxel, Carboplatin
Breast CancerФаза 2NCT07054190
Inavolisib, Ribociclib, Letrozole, Giredestrant
Ductal Carcinoma in SituФаза 2NCT06075953
Tamoxifen, Exemestane, Letrozole, Anastrazole
Breast CancerФаза 2NCT07654257
Partial Breast Irradiation
Breast CancerФаза 2NCT07748208
Inavolisib, Fulvestrant, Palbociclib
Breast CancerФаза 2NCT06361940
Aromatase inhibitors or tamoxifen
Metastatic Breast Cancer in the LiverФаза 2NCT06875128
Melphalan/HDS followed by Physician's choice of SOC (eribulin, vinorelbine, or capecitabine), Physician's choice of SOC (eribulin, vinorelbine, or capecitabine)
Estrogen Receptor-Positive Breast CarcinomaФаза 2NCT06450873
Coriolus Versicolor Extract, Questionnaire Administration
Mesothelin-Expressing TumorsPhase 1NCT06623396Papers
Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Anatomic Stage IV Breast Cancer AJCC v8Фаза 2NCT03606967
Biopsy Procedure, Biospecimen Collection, Carboplatin, Computed Tomography
Breast NeoplasmsФаза 2NCT07287098
Imlunestrant, Goserelin, Tamoxifen 20 mg
Breast CancerФаза 2NCT07368998
Inavolisib, Fulvestrant
Anatomic Stage I Breast Cancer AJCC v8Фаза 2NCT07460752
Biospecimen Collection, Goserelin Acetate, Questionnaire Administration
Breast CancerФаза 2NCT01766297
Proton Radiotherapy
Advanced Breast CancerФаза 2NCT07427394
Camizestrant, Atirmociclib
HR+/HER2- Breast Cancer Brain MetastasesPhase 1/2NCT04923542
SR & Abemaciclib With/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
Breast Cancer, MetastaticФаза 2NCT07007559
Evorpacept (ALX148), Trastuzumab, Paclitaxel, Capecitabine
Triple Negative Breast CancerФаза 2NCT05528133
Genomically Guided Radiation Therapy
ER+ Breast CancerФаза 2NCT06923527
Elacestrant
Triple Negative Breast CancerФаза 2NCT06353997
Pembrolizumab, INBRX-106
Advanced Breast CarcinomaФаза 2NCT04090567
Cediranib, Ceralasertib, Olaparib
Breast NeoplasmsФаза 2NCT06797635
Patritumab deruxtecan, Pembrolizumab, Paclitaxel, Carboplatin
Breast CancerФаза 2NCT05570253
Eribulin, SDX-7320, Placebo
Triple Negative Breast CancerФаза 2NCT06245889Papers
Paclitaxel, Carboplatin, Pembrolizumab, Doxorubicin